Natalie Ma, Ph.D.

Natalie Ma, PhD, is Head of Business Development at Deep Origin. A synthetic biologist by training with a PhD in Molecular Biology from Yale, she previously co-founded and led business and clinical development at Felix Biotechnology on phage therapies and has advised ventures across infectious disease, rare disease, and computational biology. Her work focuses on translating advanced computational and synthetic biology tools into impactful therapeutics and enabling teams to navigate the complexities of modern drug development.